Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Urinary incontinence as a result of neurogenic overactive bladder due to spinal cord injury~* Inadequate response to anticholinergic medication used to treat overactive bladder~Exclusion Criteria:~* History or evidence of pelvic or urologic abnormality~* Previous or current diagnosis of bladder or prostate cancer~* Urinary tract infection at time of enrollment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): botulinum toxin Type A (50U); botulinum toxin Type A (200U)
- 2 (Type: EXPERIMENTAL): botulinum toxin Type A (100U); botulinum toxin Type A (200U)
- 3 (Type: EXPERIMENTAL): botulinum toxin Type A (200U)
- 4 (Type: OTHER): placebo; botulinum toxin Type A (200U)

Based on this trial design, predict the completion outcome and termination type (if applicable).